Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Xiaoxi ^a   Homma, Ayaka ^a   Sayadi, Jamasb ^a,b   Yang, Shu ^c   Ohashi, Jun ^d   Takumi, Toru ^a,e  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b HARVARD COLLEGE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUIDE RNA;

CHEMISTRY; CRISPR CAS SYSTEM; DNA BASE COMPOSITION; GENE EDITING; GENE TARGETING; GENETICS;

BASE COMPOSITION; CRISPR-CAS SYSTEMS; GENE EDITING; GENE TARGETING; RNA, GUIDE;

EID: 84955598451     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19675     Document Type: Article

References (38)

1. Doudna, J. A., Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096, doi: 10.1126/science.1258096 (2014).
2. Shalem, O., Sanjana, N. E., Zhang, F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 16, 299-311, doi: 10.1038/nrg3899 (2015).
3. Sternberg, S. H., Doudna, J. A. Expanding the Biologist's Toolkit with CRISPR-Cas9. Mol Cell 58, 568-574, doi: 10.1016/j. molcel.2015.02.032 (2015).
4. Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583-588, doi: 10.1038/nature14136 (2015).
5. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442-451, doi: 10.1016/j.cell.2013.06.044 (2013).
6. Rusk, N. CRISPRs and epigenome editing. Nat Methods 11, 28 (2014).
7. Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33, 510-517, doi: 10.1038/nbt.3199 (2015).
8. O'Connell, M. R. et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 516, 263-266, doi: 10.1038/nature13769 (2014).
9. Makarova, K. S. et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9, 467-477, doi: 10.1038/nrmicro2577 (2011).
10. Hsu, P. D., Lander, E. S., Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278, doi: 10.1016/j.cell.2014.05.010 (2014).
11. Chylinski, K., Makarova, K. S., Charpentier, E., Koonin, E. V. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res 42, 6091-6105, doi: 10.1093/nar/gku241 (2014).
12. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821, doi: 10.1126/science.1225829 (2012).
13. Kabadi, A. M., Ousterout, D. G., Hilton, I. B., Gersbach, C. A. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res 42, e147, doi: 10.1093/nar/gku749 (2014).
14. Cong, L. et al. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science 339, 819-823, doi: DOI 10.1126/science.1231143 (2013).
15. Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 109, E2579-2586, doi: 10.1073/pnas.1208507109 (2012).
16. Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol 31, 839-843, doi: 10.1038/nbt.2673 (2013).
17. Nishimasu, H. et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156, 935-949, doi: 10.1016/j. cell.2014.02.001 (2014).
18. Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827-832, doi: 10.1038/nbt.2647 (2013).
19. Mandal, P. K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15, 643-652, doi: 10.1016/j.stem.2014.10.004 (2014).
20. Wang, T., Wei, J. J., Sabatini, D. M., Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80-84, doi: 10.1126/science.1246981 (2014).
21. Doench, J. G. et al. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32, 1262-1267, doi: 10.1038/nbt.3026 (2014).
22. Xu, H. et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res 25, 1147-1157, doi: 10.1101/gr.191452.115 (2015).
23. Moreno-Mateos, M. A. et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods 12, 982-988, doi: 10.1038/nmeth.3543 (2015).
24. Chari, R., Mali, P., Moosburner, M., Church, G. M. Unraveling CRISPR-Cas9 genome engineering parameters via a library-onlibrary approach. Nat Methods 12, 823-826, doi: 10.1038/nmeth.3473 (2015).
25. Ren, X. et al. Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep 9, 1151-1162, doi: 10.1016/j.celrep.2014.09.044 (2014).
26. Gagnon, J. A. et al. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of singleguide RNAs. PLoS One 9, e98186, doi: 10.1371/journal.pone.0098186 (2014).
27. Anders, C., Niewoehner, O., Duerst, A., Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569-573, doi: 10.1038/nature13579 (2014).
28. Singh, R., Kuscu, C., Quinlan, A., Qi, Y., Adli, M. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction. Nucleic Acids Res 43, e118, doi: 10.1093/nar/gkv575 (2015).
29. Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 32, 670-676, doi: 10.1038/nbt.2889 (2014).
30. Jinek, M. et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343, 1247997, doi: 10.1126/science.1247997 (2014).
31. Mouse, E. C. et al. An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol 13, 418, doi: 10.1186/gb-2012-13-8-418 (2012).
32. Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82, doi: 10.1038/nature11232 (2012).
33. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823, doi: 10.1126/science.1231143 (2013).
34. Abrahams, B. S. et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol Autism 4, 36, doi: 10.1186/2040-2392-4-36 (2013).
35. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/(2013).
36. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576-589, doi: 10.1016/j.molcel.2010.05.004 (2010).
37. Lorenz, R. et al. ViennaRNA Package 2.0. Algorithms Mol Biol 6, 26, doi: 10.1186/1748-7188-6-26 (2011).
38. Li, X., Quon, G., Lipshitz, H. D., Morris, Q. Predicting in vivo binding sites of RNA-binding proteins using mRNA secondary structure. RNA 16, 1096-1107, doi: 10.1261/rna.2017210 (2010).